The closing price of TC BioPharm (Holdings) plc ADR (NASDAQ: TCBP) was $1.70 for the day, down -5.56% from the previous closing price of $1.80. In other words, the price has decreased by -$0.1000 from its previous closing price. On the day, 1502487 shares were traded.
Ratios:
Our analysis of TCBP’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.09 and its Current Ratio is at 1.09. In the meantime, Its Debt-to-Equity ratio is 1.16 whereas as Long-Term Debt/Eq ratio is at 0.83.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TCBP now has a Market Capitalization of 4.38M and an Enterprise Value of 4.90M. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.35 while its Price-to-Book (P/B) ratio in mrq is 132.61. Its current Enterprise Value per Revenue stands at 1.72 whereas that against EBITDA is -4.11.
Stock Price History:
Over the past 52 weeks, TCBP has reached a high of $82.60, while it has fallen to a 52-week low of $0.85. The 50-Day Moving Average of the stock is 1.5677, while the 200-Day Moving Average is calculated to be 61.9545.
Shares Statistics:
TCBP traded an average of 3.26M shares per day over the past three months and 15.12M shares per day over the past ten days. Shares short for TCBP as of Feb 29, 2024 were 196.99k with a Short Ratio of 0.06, compared to 98.01k on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 8.12% and a Short% of Float of 8.12%.
Earnings Estimates
The firm’s stock currently is rated by 0 analysts. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between -$228.4 and -$228.4 for the fiscal current year, implying an average EPS of -$228.4. EPS for the following year is $0, with 0 analysts recommending between $0 and $0.
